palbociclib shows promise for treatment of brain metastases harboring cdk alterations
Published 4 years ago • 254 plays • Length 1:14Download video MP4
Download video MP3
Similar videos
-
0:55
ibrance proves promising as targeted cdk pathways in patients with brain metastases
-
5:43
cdk 4/6 inhibitor, palbociclib, for the treatment of metastatic breast cancer
-
0:52
exploring abemaciclib for the treatment of brain metastases in hr /her2- breast cancer
-
1:01
common mutations could lead to targeted treatment for patients with brain metastases
-
6:29
study of palbociclib after cdk & endocrine therapy in er /her2- metastatic breast cancer
-
1:11
novel her-2 targeted agents show promise in treating cns metastases
-
17:54
expert perspectives: cdk 4/6 inhibitors for er breast cancer: current data and clinical use
-
39:21
bcfnz webinar: palbociclib (ibrance) for advanced or metastatic hr breast cancer - nz update
-
1:07
dr. kari wisinski on palbociclib for metastatic breast cancer
-
3:03
integrating palbociclib into the treatment of breast cancer
-
0:59
dr. erika p. hamilton on difficulties of treating brain metastases in breast cancer
-
1:21
treatment approaches for brain metastases in breast cancer
-
3:05
pi3k inhibitors for the treatment of brain metastases in her2-negative breast cancer
-
2:09:50
eans webinar: brain metastases
-
1:12
results of a phase ii study of palbociclib in esophageal and gastric cancer
-
1:24
potential treatment approaches for breast cancer with brain metastases
-
0:58
the treatment of bc brain metastases
-
3:30
2020 peaprogram breast cancer series patients with brain metastases - prognosis & impact on survival
-
1:30
dr. czerniecki on treatment options for patients with her2 brain metastases